CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Wilson, Nana ^a   Driss, Adel ^a   Solomon, Wesley ^a   Dickinson Copeland, Carmen ^a   Salifu, Hassana ^a   Jain, Vidhan ^b   Singh, Neeru ^b,c   Stiles, Jonathan ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ADOLESCENT; ADULT; ARTICLE; BRAIN MALARIA; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PARASITEMIA; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CHEMOKINE CXCL10; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALARIA, CEREBRAL; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 84892582593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081329     Document Type: Article

References (50)

1. World Health Organization (2013) World Malaria Report 2012. WHO, Geneva, Switzerland. Available: http://www.who.int/malaria/publications/world-malaria- report-2012/en/. Accessed 2013 Jun 4.
2. Miller LH, Good MF, Milon G (1994) Malaria pathogenesis. Science 264: 1878-1883.
3. World Health Organization (2010) World Malaria Report 2010. Geneva, Switzerland: WHO Press. Available: http://www.who.int/malaria/world-malaria- report-2010/en/. Accessed 2013 May 9.
4. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE (2006) A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 22: 503-508.
5. Adu B, Dodoo D, Adukpo S, Gyan BA, Hedley PL, et al. (2011) Polymorphisms in the RNASE3 gene are associated with susceptibility to cerebral malaria in Ghanaian children. PLoS One 6: e29465.
6. Manjurano A, Clark TG, Nadjm B, Mtove G, Wangai H, et al. (2012) Candidate human genetic polymorphisms and severe malaria in a Tanzanian population. PLoS One 7: e47463.
7. Wilson NO, Solomon W, Anderson L, Patrickson J, Pitts S, et al. (2013) Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral Malaria. PLoS One 8: e60898.
8. Hansen DS (2012) Inflammatory responses associated with the induction of cerebral malaria: lessons from experimental murine models. PLoS Pathog 8: e1003045.
9. Brown H, Hien TT, Day N, Mai NT, Chuong LV, et al. (1999) Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 25: 331-340.
10. van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, et al. (1996) The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 174: 1091-1097.
11. Luster AD, Ravetch JV (1987) Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 166: 1084-1097.
12. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, et al. (2008) Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci U S A 105: 4814-4819.
13. Miu J, Mitchell AJ, Muller M, Carter SL, Manders PM, et al. (2008) Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol 180: 1217-1230.
14. Van den Steen PE, Deroost K, Van AI, Geurts N, Martens E, et al. (2008) CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur J Immunol 38: 1082-1095.
15. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, et al. (2007) Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J 6: 147.
16. Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, et al. (2008) Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 7: 83.
17. Wilson NO, Jain V, Roberts CE, Lucchi N, Joel PK, et al. (2011) CXCL4 and CXCL10 predict risk of fatal cerebral malaria. Dis Markers 30: 39-49.
18. Klich I, Fendler W, Wyka K, Mlynarski W (2011) Effect of the IP10 (CXCL10) and HLA genotype on the risk of type 1 diabetes in children. Pediatr Endocrinol Diabetes Metab 17: 10-13.
19. Deng G, Zhou G, Zhang R, Zhai Y, Zhao W, et al. (2008) Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 134: 716-726.
20. Tang NL, Fan HP, Chang KC, Ching JK, Kong KP, et al. (2009) Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin Chim Acta 406: 98-102.
21. Venturelli E, Galimberti D, Fenoglio C, Lovati C, Finazzi D, et al. (2006) Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease. Neurosci Lett 404: 217-221.
22. Galimberti D, Scalabrini D, Fenoglio C, Comi C, De RM, et al. (2007) CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course. Eur J Neurol 14: 162-167.
23. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN (2005) Heritability of malaria in Africa. PLoS Med 2: e340.
24. Campino S, Kwiatkowski D, Dessein A (2006) Mendelian and complex genetics of susceptibility and resistance to parasitic infections. Semin Immunol 18: 411-422.
25. Mishra SK, Mohanty S, Satpathy SK, Mohapatra DN (2007) Cerebral malaria in adults - a description of 526 cases admitted to Ispat General Hospital in Rourkela, India. Ann Trop Med Parasitol 101: 187-193.
26. Hoyert DL, Kochanek KD, Murphy SL (1999) Deaths: final data for 1997. Natl Vital Stat Rep 47: 1-104.
27. Moller AP, Sorci G, Erritzoe J (1998) Sexual dimorphism in immune defense. Am Nat 152: 605-619.
28. Zuk M, McKean KA (1996) Sex differences in parasite infections: patterns and processes. Int J Parasitol 26: 1009-1023.
29. Khan IA, MacLean JA, Lee FS, Casciotti L, DeHaan E, et al. (2000) IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12: 483-494.
30. Bihari S, Cavalcanti N, Correia JB, Alves G, Souza E, et al. (2012) Interferon gamma-induced protein-10 concentrations in children with previous tuberculosis infections and disease. Pediatr Infect Dis J 31: 1089-1091.
31. Vanini V, Petruccioli E, Gioia C, Cuzzi G, Orchi N, et al. (2012) IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect 65: 49-59.
32. Lighter J, Rigaud M, Huie M, Peng CH, Pollack H (2009) Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis 13: 731-736.
33. Dheda K, Van-Zyl Smit RN, Sechi LA, Badri M, Meldau R, et al. (2009) Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 4: e4689.
34. Strzelak A, Komorowska-Piotrowska A, Ziolkowski J (2012) [CXCL10/IP-10 as a new biomarker for Mycobacterium tuberculosis infection]. Pol Merkur Lekarski 33: 342-345.
35. Oliver BG, Elliott JH, Price P, Phillips M, Cooper DA, et al. (2012) Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens. J Acquir Immune Defic Syndr 61: 287-292.
36. Shiraki Y, Ishibashi Y, Hiruma M, Nishikawa A, Ikeda S (2008) Candida albicans abrogates the expression of interferon-gamma-inducible protein-10 in human keratinocytes. FEMS Immunol Med Microbiol 54: 122-128.
37. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, et al. (2005) Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79: 11457-11466.
38. Zhang B, Chan YK, Lu B, Diamond MS, Klein RS (2008) CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J Immunol 180: 2641-2649.
39. Mihm S, Schweyer S, Ramadori G (2003) Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J Med Virol 70: 562-570.
40. Sui Y, Potula R, Dhillon N, Pinson D, Li S, et al. (2004) Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol 164: 1557-1566.
41. Romagnani P, Crescioli C (2012) CXCL10: a candidate biomarker in transplantation. Clin Chim Acta 413: 1364-1373.
42. Dyer KD, Percopo CM, Fischer ER, Gabryszewski SJ, Rosenberg HF (2009) Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. Blood 114: 2649-2656.
43. Lo BK, Yu M, Zloty D, Cowan B, Shapiro J, et al. (2010) CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas. Am J Pathol 176: 2435-2446.
44. Sharma VP (1996) Re-emergence of malaria in India. Indian J Med Res 103: 26-45.
45. Singh S, Singh N, Handa R (2000) Tumor necrosis factor-alpha in patients with malaria. Indian J Malariol 37: 27-33.
46. Jain V, Nagpal AC, Joel PK, Shukla M, Singh MP, et al. (2008) Burden of cerebral malaria in central India (2004-2007). Am J Trop Med Hyg 79: 636-642.
47. World Health Organization (2000) Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 Suppl 1: S1-90.
48. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
49. Holding PA, Stevenson J, Peshu N, Marsh K (1999) Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg 93: 529-534.
50. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.